WS
The startup develops fully automated microfluidic molecular diagnostic systems that utilize super multiplex constant temperature amplification to accurately detect pathogenic microorganisms and cancers. Their technology provides healthcare enterprises with high-sensitivity solutions for the clinical diagnosis of complex infections, such as severe pneumonia and sepsis, as well as precision tumor diagnosis and treatment.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops fully automated microfluidic molecular diagnostic systems that utilize super multiplex constant temperature amplification to accurately detect pathogenic microorganisms and cancers. Their technology provides healthcare enterprises with high-sensitivity solutions for the clinical diagnosis of complex infections, such as severe pneumonia and sepsis, as well as precision tumor diagnosis and treatment.